• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

DOD funds evaluation of behavioral intervention for autism spectrum disorder

Bioengineer by Bioengineer
April 4, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Department of Defense is providing $7 million to better understand how much and which components of Applied Behavior Analysis (ABA) are the most effective for young children with a diagnosis of autism spectrum disorder (ASD).

As of 2017, almost 17,000 children of military personnel were receiving ABA through Tricare. ABA is often recommended at a very high intensity level, often more than 20 hours a week of individual intervention. This is often quite difficult for families to access.

Recent research suggests that ABA could be as effective when delivered at a lower intensity for some children when it is tailored to specific skills and includes effective ways of supporting parents.

“There is a great need to understand how to tailor ABA intervention approaches to individual children with ASD and their families,” said Zachary Warren, Ph.D., executive director of the Vanderbilt Kennedy Center Treatment and Research Institute for Autism Spectrum Disorders (TRIAD).

“This study will provide us with compelling data about whether a lower intensity tailored intervention may be as powerful, and potentially more desirable, as typical high intensity intervention,” he said.

The project is being coordinated through the University of Rochester School of Medicine and includes the May Institute, Cleveland Clinic and Nationwide Children’s Hospital, in addition to Vanderbilt.

ABA has been shown to be effective at increasing adaptive behaviors and decreasing challenging behaviors. The DOD study will advance current knowledge on how to best implement behaviorally-based interventions for young children with ASD by examining the impact of interventions on both children and families.

Military families have unique stressors and lifestyle needs that may include planned relocation and the need to transfer services to new providers. To ensure early identification and referral for intervention in early childhood, children of military dependents are screened for ASD in the context of routine health care.

“Often we study interventions in highly controlled intervention environments, but fail to study whether these approaches translate into the real world,” Warren said. “In this work we’re taking the work far beyond university walls to ensure that this intervention works well for military families, who often experience unique stressors and challenges.”

Children newly diagnosed with an autism spectrum disorder, ages 1½ to 5 years and referred for ABA through Tricare in North Carolina, Ohio, and Tennessee may be eligible to participate in this landmark study.

###

Media Contact
Craig Boerner
[email protected]

Tags: BehaviorMedicine/HealthMental HealthSocial/Behavioral Science
Share13Tweet8Share2ShareShareShare2

Related Posts

European Association for the Study of Obesity Endorses Semaglutide and Tirzepatide as First-Line Therapies for Obesity and Its Major Complications

October 2, 2025

Proteotoxic Stress Fuels T Cell Exhaustion, Evasion

October 2, 2025

Comparing Methods to Measure Aggregate PFAS Exposure

October 2, 2025

Spin Squeezing Achieved in Diamond NV Centers

October 2, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    91 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    73 shares
    Share 29 Tweet 18
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

European Association for the Study of Obesity Endorses Semaglutide and Tirzepatide as First-Line Therapies for Obesity and Its Major Complications

Comorbidities Impact Radiotherapy in Elderly Glioma

Can Elephants Sense When We’re Watching Them?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.